Diffusion Pharmaceuticals
DFFN
#10455
Rank
NZ$15.62 M
Marketcap
NZ$7.66
Share price
10.28%
Change (1 day)
-34.69%
Change (1 year)

Earnings for Diffusion Pharmaceuticals (DFFN)

Earnings in 2023 (TTM): -NZ$21.37 Million

According to Diffusion Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -NZ$27.14 Million, an increase over its 2021 earnings that were of -NZ$42.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Diffusion Pharmaceuticals from 1999 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$21.37 Million-21.27%
2022 -NZ$27.14 Million-36.46%
2021 -NZ$42.71 Million54.72%
2020 -NZ$27.61 Million38.32%
2019 -NZ$19.96 Million-39.03%
2018 -NZ$32.74 Million677.09%
2017 -NZ$4.22 Million-86.85%
2016 -NZ$32.03 Million-22.75%
2015 -NZ$41.46 Million38.74%
2014 -NZ$29.89 Million598.54%
2013 -NZ$4.28 Million-57.56%
2012 -NZ$10.08 Million-62.43%
2011 -NZ$26.84 Million58.75%
2010 -NZ$16.91 Million238.41%
2009 -NZ$5 Million189.55%
2008 -NZ$1.73 Million1576.75%
2007 -NZ$0.11 Million-35.01%
2006 -NZ$0.16 Million
1999 -NZ$12.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion 1,031.69%๐Ÿ‡บ๐Ÿ‡ธ USA